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Objective The aim of this study was to investigate the
physiopathology of isolated or coexisting ureteropelvic
junction obstruction (UPJ-O) and high-grade vesicoureteral
reflux (VUR), including the clinical characteristics and
management.
Summary background data The association between
UPJ-O and VUR was reported more frequently in boys
with high-grade VUR; however, the physiopathology of
concomitant UPJ-O and VUR is still unknown. Primary
pyeloplasty, followed by ureteral reimplantation, if needed,
has been widely accepted, although VUR should be treated
first (most often by endoscopic treatment) in the presence
of a functional obstruction.
Methods We reviewed the charts of 78 children with
isolated or coexisting high-grade VUR/UPJ-O. Among the
children, 14 had isolated UPJ-O, 16 had high-grade VUR/
UPJ-O, and 48 had high-grade VUR. Children with other
urological or extrarenal conditions were excluded.
Results Patients with isolated UPJ-O showed significantly
different clinical characteristics compared with the other
two groups of patients with high-grade VUR. Among the
patients of group 2, 3/13 (23%) showed progression from
functional to obstructive UPJ-O after endoscopic treatment.
All of them underwent secondary pyeloplasty, which was
complicated at follow-up by VUR recurrence needing
further endoscopic injection.
Conclusion We suggest that UPJ-O in high-grade VUR
patients is just a complication of severe VUR that produces
structural changes in predisposed children. The treatment
of children with associated high-grade VUR/UPJ-O may be
complicated by the progression of urinary flow obstruction
or VUR recurrence after pyeloplasty. Endoscopic treatment
of high-grade VUR is associated with a high rate of VUR
recurrence in children requiring subsequent
pyeloplasty. Ann Pediatr Surg 9:114–116 c 2013 Annals of
Pediatric Surgery.
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Introduction
Historically, the association between ureteropelvic junc-
tion obstruction (UPJ-O) and vesicoureteral reflux
(VUR) was reported more frequently in boys with high-
grade VUR, with a range from 9 to 14% [1,2]. In a large
series including 224 children with UPJ-O, the incidence
of ipsilateral VUR was found to be 18%. Further, a five-
fold increased risk of UPJ-O in children with high-grade
VUR was also reported; however, when all grades of VUR
were considered, an increased risk of obstruction was not
observed [3]. Furthermore, in another study, records of
143 children with prenatally diagnosed hydronephrosis
secondary to UPJ-O as well its association with clinical
features such as prematurity, twinning, and urological
anomalies were analyzed. It was found that pyeloplasty
was required more often in children with associated VUR
(54.5 vs. 18.2%) [4].
The physiopathology of concomitant UPJ-O and VUR is
still unknown. Several hypotheses have been proposed
including, association or causality, early developmental
anomalies during the evolutional process of the ureteral
bud ascending toward the primitive metanephric blas-
tema, tortuosity, kinking and inflammation, and primary
or secondary changes of the ureteral barrier at the UPJ.
However, none of these hypotheses have been proven yet.
Primary pyeloplasty, followed by ureteral reimplantation,
if needed, has been widely accepted. This surgical
strategy is justified by two observations: (a) even high-
grade VUR may improve spontaneously, (b) primary
reimplantation may cause acute deterioration of an
already obstructed UPJ [1,2]. In contrast, VUR should
be treated first in the presence of a functional ob-
struction [2]. Actually, the preferred surgical treatment
for VUR is by endoscopic treatment (ET) in all grades
with a percentage of improvement/resolution greater than
90% [5,6].
The aim of this retrospective study was to investigate the
differences in clinical characteristics and management in
children with isolated or coexisting UPJ-O and high-grade
VUR. Furthermore, we demonstrated that high-grade
VUR may play a role in the development of secondary
ipsilateral UPJ-O.
Patients and methods
During a 6-year period, we operated upon 126 children
with high-grade VUR or/and UPJ-O. All patients (48/126
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patients) with other associated renal (duplex kidney,
horseshoe kidney, ureterocele, controlateral VUR, spina
bifida, etc.) or extrarenal diseases (down syndrome,
calcolosis, oesophageal atresia, etc.) were excluded from
the study. UPJ-O was diagnosed using renal ultrasounds,
voiding urethrocystography, and diuretic 99mTc MAG3
renal scans. The diuretic renal scan was performed
according to the guidelines for the ‘well-tempered’
diuretic renogram using a bladder catheter [7]. An
injection of 50 Ci/kg of 99mTc MAG3 was followed by a
20-min baseline observation (renogram phase). Children
who did not eliminate at least 50% of the labelled
substance in the pelvis (T1/2) underwent furosemide
stimulation (1 mg/kg endovenous bolus). Elimination was
monitored for another 20 min. Patients who did not
achieve T1/2 by the end of the test (T1/2 > 20 min) were
diagnosed with ‘obstructive’ UPJ-O, whereas those who
achieved T1/2 (T1/2r 20 min) were diagnosed with
‘functional’ UPJ-O. Finally, a normal urinary flow was
defined when T1/2 was reached within 10 min from
injection of the radionuclide.
Seventy-eight patients were included in the study. The
mean follow-up duration was 35 ± 17 months (median 31).
The patients were divided into three groups: (a) the isolated
obstructive UPJ-O group (14 patients), (b) the coexisting
ipsilateral high-grade VUR/UPJ-O group (16 patients), and
(c) the isolated high-grade VUR group (48 patients). None
of the children with low-grade VUR had UPJ-O. For each
group, the following clinical characteristics were studied:
age at surgery, sex, affected side, history of urinary tract
infection (UTI), bladder dysfunction, and split renal
function (SRF) up to 45% (Table 1). Bladder dysfunctions
included a reduced capacity and an underactive or
overactive bladder requiring medical treatment.
The indications for surgery in UPJ-O included an
obstructive slope curve coexisting with (a) SRF of up to
45%, (b) a persistent obstructive curve at the 6 month-
follow-up renal scan, or (c) recurrent abdominal pain or
UTIs despite antibiotic prophylaxis.
The indications for ET of VUR included (a) recurrent or
breakthrough UTI, (b) moderate or high-grade VUR, (c)
renal scars on dimercaptosuccinic acid renal scans, (d)
SRF, (e) VUR persistence over 5 years of age, and (f) poor
compliance to antibiotic prophylaxis. High-grade VUR
was defined mainly according the international system of
radiographic grading of VUR [8].
However, in patients with coexisting ipsilateral UPJ-O,
the main finding used to grade VUR was the dilatation
and tortuosity of the ureter, because the pelvicaliceal
morphology could have been influenced by UPJ-O.
Pyeloplasty was performed through a mini-flank lapar-
otomy. Thereafter, the child was sent back home on
antibiotic prophylaxis (in patients with ipsilateral VUR, a
bladder catheter was left in place for a week). The
pyelovesical stent was removed during the second post-
operative week by cystoscopy.
In this series of patients, polydimethylsiloxane (Macro-
plastique, MPQ; Uroplasty BV, Geleeen, the Netherlands)
was the usual bulking agent for ET in high-grade VUR;
however, dextran-hyaluronic acid (Deflux; Oceana Ther-
apeutics Ltd., Dublin, Ireland) was also offered as an
alternative implant.
Standard follow-up comprised regular renal ultrasounds
every 6 months for 2 years and then every year,
cystography, and, more recently, cystosonography or
cystoscintigraphy after 3 months and after 1 year. A
diuretic 99mTc MAG3 renal scan was obtained after 2
years, unless progressive UPJ-O was suspected by a renal
US. All patients were operated upon or monitored by the
same surgeon who has expertise in homogeneous manage-
ment and treatment.
Statistical analysis
Statistical analysis was done using SPSS v.15 (Chicago,
Illinios, USA). Quantitative data were analyzed using 1
way ANOVA test; while qualitative data were analyzed
using Chi square. The difference was considered
significant when P value was less than 0.05.
Approval of the ethical committee for this research was
obtained.
Results
Among patients with ipsilateral coexisting UPJ-O/high-
grade VUR, urinary flow impairment was graded func-
tional in 13/16 patients (81%) and obstructive in the
remaining 3/16 patients (19%). In Table 1, the group-
based clinical characteristics of all the three groups are
reported (age at surgery, sex, affected side, history of
UTI, bladder dysfunction, and SRFr 45%). Group 1 was
significantly different from groups 2 and 3 with regard to
sex (P < 0.05), affected side (P < 0.05), history of UTI
(P < 0.01), bladder dysfunction (P < 0.01), and SRF of up
to 45% (P < 0.01). Group 2 did not show significant
differences compared with group 3, except for only a
slightly higher percentage of history of UTI and SRF up
to 45% (P = NS). No age differences were observed
among all the three groups.
The treatment options according to the group were: (a)
group 1, primary pyeloplasty (100%); (b) group 2, primary
pyeloplasty, followed by ET in patients with obstructive
UPJ-O (19%) or ET and observation in patients with
functional UPJ-O (81%); and (c) group 3, primary ET
(100%).
All patients in group 1 had an obstructive UPJ-O.
Table 1 Clinical characteristics according to age, sex, laterality of
disease, history of UTI, bladder dysfunction, and split renal
functionr45% for all groups of patients
Group 1 Group 2 Group 3
Mean age ± SD (months) 41 ± 43 42 ± 33 41 ± 26
Sexa 11 M, 3 F 8 M, 8 F 20 M, 28 F
Lateralitya 6 RT, 6 LT, 2 BIL 6 RT, 10 LT 11 RT, 22 LT, 15 BIL
UTI (%)a 27 75 61
Bladder dysfunction (%)a 9 25 39
SRFr45% (%)a 45 92 80
BIL, bilateral; F, female; LT, left side; M, male; RT, right side; SRF, split renal
function; UTI, urinary tract infection.
aStatistical differences between group 1 versus groups 2 and 3.
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In group 2, 3/13 patients (23%) with functional UPJ-O/
high-grade VUR progressed to obstructive UPJ-O and
required secondary pyeloplasty. At 1-year follow-up after
secondary pyeloplasty, all of them had recurrent VUR,
which was successfully treated by redo ET. All children
who underwent redo injection had implant displacement.
The incidence of significant UPJ-O in patients with high-
grade VUR was 16/64 (25%). In this study, six (33%) of
the 20 patients who underwent pyeloplasty had ipsilateral
UPJ-O/high-grade VUR.
In group 3, 45/48 patients (94%) had resolution of VUR/
improvement to grade 1 after ET, whereas the other three
required ureteral reimplantation.
Discussion
Our results showed that ipsilateral UPJ-O/high-grade
VUR has a higher occurrence compared with what has
been reported in the literature (25%). This study also
showed that patients with isolated UPJ-O have clinical
characteristics different from children with UPJ-O/high-
grade VUR and high-grade VUR, whereas no significant
differences were seen in both groups with severe VUR
(group 2 vs. group 3; P = NS). These findings support the
hypothesis that UPJ-O/high-grade VUR may be an
evolving process complicating the natural course of
patients with severe VUR. In fact, the hypothesis based
on association lacks evidence on the basis of the poor
statistical probability that both diseases occur simulta-
neously but act independently. Most likely, causality, that
is, one factor influencing the other, may explain how high-
grade reflux causes UPJ-O. Previously, it has been
proposed that severe reflux causes kinking of the UPJ,
which becomes fixed secondary to inflammation. Criti-
cism to this hypothesis was that, in the face of persistent
reflux, hydronephrosis would persist despite pyeloplasty,
and there would be a risk of recurrent obstruction.
Furthermore, ureteric reimplantation would protect
against progressive UPJ-O or, as an alternative, would
lead to its resolution. In clinical practice, these relation-
ships are often opposite to what is expected as a
consequence of the above-mentioned hypotheses. In
fact, pyeloplasty is effective despite persistent severe
VUR, and treatment of VUR may cause progression from
functional to obstructive UPJ-O. In our series, we
observed this progression in 23% of patients. This
percentage is much lower than that reported by another
study in which it was observed that five children with
high-grade VUR and functional UPJ-O underwent
primary ureteroneocystostomy. All five children devel-
oped progressive obstruction requiring subsequent pye-
loplasty [3]. In our opinion, this finding may be related to
a difference in the antireflux procedure. However, this
observation needs at least two answers that have not yet
been provided: does ureteric reimplantation produce
higher resistance at the ureterovesical junction when
compared with ET? And does it (the different pressure
gradient at the ureterovesical junction) influence urinary
flow at the ureteropelvic junction, especially if it was
already damaged? We hypothesized that damage of the
urothelial barrier could play an important role in the
progression of functional hydronephrosis into an obstruc-
tion [9]. Furthermore, a higher rate of pyeloplasty has
been reported in patients with associated reflux com-
pared with patients without VUR. This observation
suggests that simultaneous occurrence of UPJ-O and
VUR may not be coincidental but rather the consequence
of common casuality and/or common pathogenesis [4].
Interestingly, all patients successfully treated for primary
VUR with coexistent functional UPJ-O who subsequently
underwent pyeloplasty developed VUR recurrence. To
our knowledge, this finding has not been reported yet. In
fact, pyeloplasty in patients with previous ureteroneocys-
tostomy does not cause VUR recurrence. The reason why
ureters treated by ET develop VUR recurrence after
pyeloplasty is unknown; however, displacement of the
implant may play a role. All our patients underwent
successful redo ET and had an uneventful follow-up.
Conclusion
We believe that patients with isolated UPJ-O have
clinical characteristics different from those with high-
grade VUR or UPJ-O/high-grade VUR wherein obstruc-
tion seems to be secondary to severe reflux. The ET of
children with associated UPJ-O/high-grade VUR may be
complicated by progression of urinary flow obstruction at
a lower rate. VUR recurrence after pyeloplasty should be
expected if reflux has been managed endoscopically.
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